Trial Profile
A Two Phase, Double-blinded, Randomized, Parallel Group Design, Multicenter Study of FLOMAX Capsules, 0.4 mg Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Tamsulosin (Primary)
- Indications Urinary retention
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 25 Sep 2014 New trial record